Andrew J. Spillane
- Oncology top 0.5%
- Cutaneous Melanoma Detection and Management 85
- Global Cancer Incidence and Screening 30
- CAR-T cell therapy research 29
- Cancer Immunotherapy and Biomarkers 27
- Cancer Research top 1%
- Breast Cancer Treatment Studies 67
-
- Breast Lesions and Carcinomas 31
- Dermatology top 2%
-
- Breast Implant and Reconstruction 38
-
- Melanoma and MAPK Pathways 35
- Co-authors
- Meagan BrennanJohn F. ThompsonRobyn P.M. SawRichard A. ScolyerJonathan R. StretchPhyllis ButowKerwin F. ShannonKathy Flitcroft
- Partner nations
- AustraliaNetherlandsUnited Kingdom
In The Last Decade
Andrew J. Spillane
205 papers receiving 4.4k citations
Peers
Comparison fields: 5 of 120
- Oncology 2.8k
- Cancer Research 1.1k
- Pathology and Forensic Medicine 658
- Dermatology 249
- Pulmonary and Respiratory Medicine 921
Countries citing papers authored by Andrew J. Spillane
This map shows the geographic impact of Andrew J. Spillane's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Andrew J. Spillane with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Andrew J. Spillane more than expected).
Fields of papers citing papers by Andrew J. Spillane
This network shows the impact of papers produced by Andrew J. Spillane. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Andrew J. Spillane. The network helps show where Andrew J. Spillane may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Andrew J. Spillane, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 0 | |
| 2 | 2025 | 0 | |
| 3 | 2024 | 1 | |
| 4 | 2024 | 0 | |
| 5 | 2024 | 0 | |
| 6 | 2024 | 0 | |
| 7 | 2023 | 6 | |
| 8 | 2023 | 6 | |
| 9 | 2023 | 7 | |
| 10 | 2023 | 0 | |
| 11 | 2022 | 8 | |
| 12 | 2022 | 5 | |
| 13 | 2021 | 23 | |
| 14 | 2021 | 5 | |
| 15 | 2019 | 9 | |
| 16 | 2019 | 1 | |
| 17 | 2019 | 2 | |
| 18 | 2019 | 10 | |
| 19 | 2018 | 10 | |
| 20 | 2018 | 1 |
About Andrew J. Spillane
Andrew J. Spillane is a scholar working on Oncology, Cancer Research and Pathology and Forensic Medicine, having authored 218 papers that have together received 4.5k indexed citations. Recurring topics across this work include Cutaneous Melanoma Detection and Management (85 papers), Breast Cancer Treatment Studies (67 papers), Breast Implant and Reconstruction (38 papers), Melanoma and MAPK Pathways (35 papers), Breast Lesions and Carcinomas (31 papers), Global Cancer Incidence and Screening (30 papers), CAR-T cell therapy research (29 papers) and Cancer Immunotherapy and Biomarkers (27 papers). The work is most often cited by research in Oncology (2.8k citations), Cancer Research (1.1k citations) and Pathology and Forensic Medicine (658 citations). Andrew J. Spillane has collaborated with scholars based in Australia, Netherlands and United Kingdom. Frequent co-authors include Meagan Brennan, John F. Thompson, Robyn P.M. Saw, Richard A. Scolyer, Jonathan R. Stretch, Phyllis Butow, Kerwin F. Shannon, Kathy Flitcroft, Cyril Fisher and Janet Thomas. Their work appears in journals such as The Lancet, Nature Medicine and Journal of Clinical Oncology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.